Custos catastróficos e sequelas sociais decorrentes do diagnóstico e tratamento da tuberculose no Brasil

Objective: To assess the impact of catastrophic costs on the unfavorable outcome of tuberculosis treatment. Methods: This is prospective cohort made in five capitals of Brazilian states (Manaus, Recife, Vitória, Campo Grande and Porto Alegre) between June 2016 and July 2018. Logistic regression was used to calculate odds ratios (OR) and 95% confidence intervals (95%CI). Results: The 350 participants, 310 were included, and 30 had unfavorable outcome. Catastrophic cost (OR=2.53 – 95%CI 1.13;5.67) and divorce episode (OR=5.29 – 95%CI 1.39;20.05) increased the chance of unfavorable outcome. Conclusion: financial difficulties faced during the treatment of tuberculosis can impair the treatment outcome. The determinants for the treatment outcome were catastrophic cost and divorce.Objetivo: Avaliar o impacto dos custos catastróficos no desfecho desfavorável do tratamento da tuberculose. Métodos: Estudo de coorte prospectiva, realizado em cinco capitais de estados brasileiros (Manaus, Recife, Vitória, Campo Grande e Porto Alegre) no período de junho de 2016 a julho de 2018. Empregou-se regressão logística para calcular a razão de chances (odds ratio, OR) e os intervalos de confiança de 95% (IC95%). Resultados: Dos 350 participantes, 310 foram incluídos, dos quais 30 apresentaram desfecho desfavorável. Custo catastrófico (OR=2,53 – IC95% 1,13;5,67) e divórcio (OR=5,29 – IC95% 1,39;20,05) aumentaram as chances de desfecho desfavorável. Conclusão: Dificuldades financeiras durante o tratamento da tuberculose podem prejudicar seu desfecho. Os fatores determinantes para o desfecho do tratamento foram custo catastrófico e divórcio

The economic burden of households affected by tuberculosis in Brazil: First national survey results, 2019-2021.

BackgroundOne of the three main targets of the World Health Organization (WHO) End TB Strategy (2015-2035) is that no tuberculosis (TB) patients or their households face catastrophic costs (defined as exceeding 20% of the annual household income) because of the disease. Our study seeks to determine, as a baseline, the magnitude and main drivers of the costs associated with TB disease for patients and their households and to monitor the proportion of households experiencing catastrophic costs in Brazil.MethodsA national cross-sectional cluster-based survey was conducted in Brazil in 2019-2021 following WHO methodology. TB patients of all ages and types of TB were eligible for the survey. Adult TB patients and guardians of minors (ResultsWe interviewed 603 patients, including 538 (89%) with drug-sensitive (DS) and 65 (11%) with drug-resistant (DR) TB. Of 603 affected households, 48.1% (95%CI: 43-53.2) experienced costs above 20% of their annual household income during their TB episode. The proportion was 44.4% and 78.5% among patients with DS- and DR-TB, respectively. On average, patients incurred costs of US$1573 (95$317.6, 95%CI: 232.7-402.6) followed by medical costs (US$85.5, 95$79.2, 95%CI: 61.9-96.5). In multivariate analysis, predictors of catastrophic costs included positive HIV status (aOR = 3.0, 95%CI:1.1-8.6) and self-employment (aOR = 2.7, 95%CI:1.1-6.5); high education was a protective factor (aOR = 0.1, 95%CI:0.0-0.9).ConclusionsAlthough the services offered to patients with TB are free of charge in the Brazilian public health sector, the availability of free diagnosis and treatment services does not alleviate patients' financial burden related to accessing TB care. The study allowed us to identify the costs incurred by patients and suggest actions to mitigate their suffering. In addition, this study established a baseline for monitoring catastrophic costs and fostering a national policy to reduce the costs to patients for TB care in Brazil